MENUCLOSE

 

Connect with us

Tag : clinical trial readiness

ArcheMedX Releases New Oncology Findings Ahead Of ESMO Congress Revealing Clinician Readiness

2021 was a historic year in the battle to defeat cancer.   More novel cancer treatments became available than ever before with the number of Oncology specific clinical trials also reaching an all-time high, up 56% from 2016 and mostly focused on rare cancer indications. With global spending on Oncology expected to exceed $300

Pandemic Impact on Clinical Trial Recruitment with Atul Mahableshwarkar, M.D., DFAPA

Atul Mahableshwarkar, M.D., DFAPA, joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss clinical trial methodology. A self-described “trial nerd,” Atul illuminates the make-or-break role methodology plays in a trial’s success and shares his advice and best practices for making positive outcomes possible. Enjoy this interview

Increasing Access to People of African Descent in Pharma: Interview with Peju Oshisanya

Peju Oshisanya joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss diversity and inclusion in clinical trials. An experienced clinical operations specialist and a strong advocate for data diversity, Peju shares her insight into the health sciences industry, evaluates opportunities for improvement, and illuminates the

Successful Clinical Trial Management Now Means Accepting Complexity. Here’s How to Deal with It.

If it shocks you to hear that clinical trials are getting more complex, you haven’t been paying attention. Specifically, we’re collecting more endpoints. We’re performing more procedures. We’re increasing nearly every executional variable, like the number of countries, the number of sites, the number of visits per patient, and the